Effects of fluoxetine on the anticonvulsant action of valproate and ethosuximide in mouse model of myoclonic convulsions

• Autorzy: Borowicz K. K. , Piskorska B. , Stepniak B. , Czuczwar S. J.
• Języki publikacji: EN

Abstrakty

EN

Depression is becoming a growing problem in rural areas. This psychiatric disorder often accompanies epilepsy. The aim of this study was to assess the influence of fluoxetine (FXT), a commonly used antidepressant, on the protective action of two conventional antiepileptic drugs: ethosuximide (ETX) and valproate (VPA), against pentylenetetrazole (PTZ)-induced convulsions in mice. Motor coordination and long-term memory deficits induced by FXT, antiepileptic drugs alone and in combinations with FXT were assessed in the chimney test and passive-avoidance task, respectively. Brain concentrations of ETX and VPA were measured by immunofluorescence. Obtained results indicate that FXT at the dose of 15 mg/kg (ip, 30 min before the test) significantly increased the threshold for clonic convulsions. The antidepressant drug at lower doses remained ineffective in this respect. Moreover, FXT at the highest subprotective dose (10 mg/kg, ip) markedly enhanced the anticonvulsant effects of VPA, but not of ETX, against PTZ-induced seizures. The interaction between FXT and VPA seems to be pharmacodynamic because the antidepressant drug did not alter the brain concentration of VPA. With regard to adverse effects, FXT, VPA, ETX, and the combinations of FXT with antiepileptic drugs, did not impair motor coordination and long-term memory in mice. In conclusion, the combination of FXT with VPA may be advantageous in the treatment of myoclonic epilepsy, and therefore it should be recommended for further study in clinical conditions.

• Wydawca: -
• Czasopismo: Annals of Agricultural and Environmental Medicine
• Rocznik: 2012
• Tom: 19
• Numer: 3
• Opis fizyczny: p.487-490,fig.,ref.

Twórcy

autor

Borowicz K. K.

• Experimental Neuropathophysiology Unit, Department of Pathophysiology, Medical University, Lublin, Poland

autor

Piskorska B.

• Experimental Neuropathophysiology Unit, Department of Pathophysiology, Medical University, Lublin, Poland

autor

Stepniak B.

• Experimental Neuropathophysiology Unit, Department of Pathophysiology, Medical University, Lublin, Poland

autor

Czuczwar S. J.

• Experimental Neuropathophysiology Unit, Department of Pathophysiology, Medical University, Lublin, Poland; Department of Physiopathology, Institute of Rural Health, Lublin, Poland

Bibliografia

• 1. Wojszel B, Bień B. The spreading of big geriatric center in the community dwelling elderly: the challenge for the primary health care. Przeg Lek.2002; 59: 216-221.
• 2. Mazarati A, Siddarth P, Baldwin RA, Shin D, Caplan R, Sankar R. Depression after status epilepticus: behavioural and biochemical deficitsand effects of fluoxetine. Brain 2008; 131: 2071-2083.
• 3. Seethalakshmi R, Krishnamoorthy E S. Depression in epilepsy: phenomenology, diagnosis and management. Epileptic Disord. 2007; 9: 1-10.
• 4. Jackson M J, Turkington D. Depression and anxiety in epilepsy. J Neurol Neurosurg Psychiatry 2005; 76: 45-7.
• 5. Prueter C, Norra C. Mood disorders and their treatment in patients with epilepsy. J Neuropsychiatry Clin Neurosci. 2005; 17: 20-28.
• 6. Isbister GK, Bowe S J, Dawo A, Whyte I M. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. Clin Toxicol. 2004;42: 277-285.
• 7. Hasler G, Bonwetsch R, Giovacchini G, Toczek M T, Bagic A, Luckenbaugh D A, Drevets WC, Theodore WH. 5-HT1A receptorbinding in temporal lobe epilepsy patients with and without majordepression. Biol Psychiatry 2007; 62: 1258-1264.
• 8. Merrill M A, Clough R W, Dailey J W, Jobe P C, Browning RA. Localization of the serotonergic terminal fields modulating seizuresin the genetically epilepsy-prone rat. Epilepsy Res. 2007; 76: 93-102.
• 9. Borowicz K K, Furmanek-Karwowska K, Sawicka K, Luszczki JJ, Czuczwar S J. Chronically administered fluoxetine enhances the anticonvulsant activity of conventional antiepileptic drugs in the mousemaximal electroshock model. Eur J Pharm. 2007; 567: 77-82.
• 10. Borowicz K K, Stępień K, Czuczwar S J. Fluoxetine enhances the anticonvulsant effects of conventional antiepileptic drugs in maximal electroshock seizures in mice. Pharm Rep. 2006; 58: 83-90.
• 11. Ugale R R, Mittal N, Hirani K, Chopde C T. Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsantaction of fluoxetine against pentylenetetrazole-inducend seizures inmice. Brain Res. 2004; 1023: 102-111.
• 12. Ferrero A J, Cereseto M, Reinés A, Bonavita C D, Sifonios L L, Rubio M C, Wikinski S I. Chronic treatment with fluoxetine decreases seizurethreshold in naïve but not in rats exposed to the learned heplessnessaradigm: Correlation with the hippocampal glutamate release. ProgNeuropsychopharmacol Biol Psychiatry 2005; 29: 678-686.
• 13. Zienowicz M, Wisłowska A, Lehner M, Taracha E, Skórzewska A, Maciejak P, Płaźnik A. The effect of fluoxetine in a model of chemicallyinduced seizures – behavioral and immunocytochemical study. Neurosci Lett. 2005; 373: 226-231.
• 14. Boissier J R, Tardy J, Diverres J C. Une nouvelle methode simple pour explorer l’action’tranquilisante: le test de la cheminee. Med Exp. (Basel)1960; 3: 81-84.
• 15. Venault P, Chapouthier G, De Carvalho L P, Simiand J, Morre M, Dodd R H, Rossier J. Benzodiazepines impair and betacarbolines enhanceperformance in learning and memory tasks. Nature 1986; 321: 864-866.
• 16. Litchfield J T, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 1949; 96: 99-113.
• 17. Łuszczki J J, Czuczwar S J. How significant is the difference between drug doses influencing the threshold for electroconvulsions? PharmacolRep. 2005; 57: 782-786.
• 18. Szasz B K, Mike A, Karoly R, Gerevich Z, Illes P, Vizi ES, Kiss J P. Direct inhibitory effect of fluoxetine on N-methyl-D-aspartate receptors in thecentral nervous system. Biol Psychiatry 2007; 62: 1303-1309.
• 19. Peričić D, Lazić J, Švob Štrac D. Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice. BrainRes 2005; 1033: 90-95.
• 20. Ceyhan M, Kayir H, Uzbay I T. Investigation of the effects of tianeptine and fluoxetine on pentylenetetrazole-induced seizures in rats. JPsychiatr Res. 2005; 39: 191-196.
• 21. Zienowicz M, Wisłowska-Stanek A, Lehner M, Taracha E, Skórzewska A, Bidziński A, Turzyńska D, Sobolewska A, Walkowiak J, MaciejakP, Szyndler J, Płaźnik A. Fluoxetine attenuates the effects ofpentylenetetrazol on rat freezing behavior and c-Fos expression inthe dorsomedial periaqueductal gray. Neurosci Lett. 2007; 414: 252-256.
• 22. Romero L, Artigas F. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphepathway: role of somatodendritic autoreceptors. J Neurochem. 1997;68: 2593-2603.
• 23. Deak F, Lasztoczi B, Pacher P, Petheo GL, Kecskemeti V, Spat A. Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology 2000; 39: 1029-1036.

Uwagi

rekord w opracowaniu